Organization: Patented Medicine Prices Review Board Canada
Year: 2020
Month: December
Request Number: A-2020-18442
Request Summary: A detailed summary of all occasions the PMPRB has used the excessive price penalty for pharmaceutical companies, broken down by date, company penalized, the name of the drug in question, the amount penalized, and a summary of why the price was excessive. Additionally, provide details of how much was collected under the penalty for the past five years and how the money gained from the penalties was used.
Disposition: All disclosed
Number of pages: 2